Certara
在场
高管
查看带有其 25 名主要高管的组织结构图
Certara 搜索最多的简介
- William Feehery, Chief Executive Officer and Director
- Stephen McLean, Director
- Matthew Walsh, Director
高管在Certara变化
- John Reynders已作为Independent Board Member加入公司 (新闻发布的2024十月18号).
- Daniel Corcoran已作为General Counsel加入公司 (新闻发布的2024五月22号).
- Rona Anhalt已作为Chief Human Resources Officer加入公司 (新闻发布的2024五月22号).
创建提醒
跟踪 Certara 的高管变动
药店
Certara 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Certara 的最新新闻稿
- Certara Showcases 2024 Research Wins with Over 100 Papers Published
- Certara Reports Third Quarter 2024 Financial Results
- Certara Appoints John Reynders as New Independent Board Member
- Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
- Certara Completes Acquisition of Chemaxon
- Certara’s Simcyp Consortium Celebrates 25th Anniversary
- Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
- Certara to Participate in Upcoming Investor Conferences
- Certara Reports Second Quarter 2024 Financial Results
- Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
- View more press releases Close
关于 Certara 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 William Feehery 
